Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorRomero Laorden, N.
dc.contributor.authorLorente, D.
dc.contributor.authorLozano Mejorada, R.
dc.contributor.authorSanchez-Soler, N.
dc.contributor.authorDe Velasco, G.
dc.contributor.authorPuente, J.
dc.contributor.authorBorrega, P.
dc.contributor.authorGonzalez-Billalabeitia, E.
dc.contributor.authorCastillo-Morales, V.
dc.contributor.authorHernandez, A.
dc.contributor.authorFernandez-Freire, A.
dc.contributor.authorLopez Campos, F.
dc.contributor.authorVillatoro, R.
dc.contributor.authorFernandez Calvo, O.
dc.contributor.authorAnido, U.
dc.contributor.authorLainez, N.
dc.contributor.authorLuque, R.
dc.contributor.authorRos Martinez, S.
dc.contributor.authorCastro, E.
dc.contributor.authorOlmos, D.
dc.contributor.authoraffiliation[Romero Laorden, N.] Hosp Univ La Princesa, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Lorente, D.] Consorci Hosp Prov Castellon, Med Oncol Dept, Castellon de La Plana, Spain
dc.contributor.authoraffiliation[Lozano Mejorada, R.] CNIO Ctr Nacl Invests Oncol, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Olmos, D.] CNIO Ctr Nacl Invests Oncol, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez-Soler, N.] IBIMA, Inst Invest Biomed Malaga, Urol Dept, Malaga, Spain
dc.contributor.authoraffiliation[De Velasco, G.] Univ Hosp 12 Octubre, Med Oncol Dept, Madrid, MA, Spain
dc.contributor.authoraffiliation[Puente, J.] CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Borrega, P.] Hosp San Pedro Alcantara, Med Oncol Dept, Caceres, Spain
dc.contributor.authoraffiliation[Gonzalez-Billalabeitia, E.] Hosp Univ Morales Meseguer, Med Oncol Dept, Murcia, Spain
dc.contributor.authoraffiliation[Castillo-Morales, V.] Hosp Univ La Princesa, Nucl Med, Madrid, Spain
dc.contributor.authoraffiliation[Hernandez, A.] Onkologikoa, Med Oncol Dept, Donostia San Sebastian, Spain
dc.contributor.authoraffiliation[Fernandez-Freire, A.] Hosp Torrecardenas, Med Oncol Dept, Almeria, Spain
dc.contributor.authoraffiliation[Lopez Campos, F.] Hosp Univ Ramon & Cajal, Radiat Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Villatoro, R.] Hosp Costa Sol, Med Oncol Dept, Marbella, Spain
dc.contributor.authoraffiliation[Fernandez Calvo, O.] Complejo Hosp Ourense, Med Oncol Dept, Orense, Spain
dc.contributor.authoraffiliation[Anido, U.] Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
dc.contributor.authoraffiliation[Lainez, N.] Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain
dc.contributor.authoraffiliation[Luque, R.] Hosp Univ Virgen Las Nieves, Med Oncol Dept, Granada, Spain
dc.contributor.authoraffiliation[Ros Martinez, S.] Hosp Univ Virgen La Arrixaca, Med Oncol Dept, Murcia, Spain
dc.contributor.authoraffiliation[Castro, E.] Hosp Univ Virgen La Victoria, Dept Med Oncol, Malaga, Spain
dc.contributor.funderBayer + academic
dc.date.accessioned2025-01-07T12:49:11Z
dc.date.available2025-01-07T12:49:11Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1119
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1119
dc.identifier.urihttps://hdl.handle.net/10668/24957
dc.identifier.wosID700527701070
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Torrecárdenas
dc.organizationSAS - Hospital Universitario Torrecárdenas
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Costa del Sol
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.numberS648-S648
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleRole of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Torrecárdenas
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Costa del Sol
SAS - Hospital Universitario Virgen de la Victoria
SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía